The Trump administration signed a Section 123 civilian nuclear cooperation agreement with Saudi Arabia in late July 2026, establishing a framework for U.S. technology transfers and a potential 30-year partnership. However, President Trump subsequently conditioned the deal’s approval on Saudi Arabia normalizing relations with Israel via the Abraham Accords, a step Riyadh has not taken and shows no immediate signs of pursuing amid regional tensions. Under the Atomic Energy Act, the agreement requires submission to Congress for a 90-day review period before it can enter into force, a timeline that already compresses the remainder of 2026. Unresolved details on uranium enrichment, IAEA safeguards, and bipartisan congressional concerns over proliferation risks further complicate prospects. These procedural, diplomatic, and political hurdles underpin trader expectations that the agreement will not take effect this calendar year.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated$14,574 Vol.
$14,574 Vol.
$14,574 Vol.
$14,574 Vol.
The resolution source for this market will be a consensus of credible reporting.
Market Opened: Jul 22, 2026, 7:10 PM ET
Resolver
0x65070BE91...The resolution source for this market will be a consensus of credible reporting.
Resolver
0x65070BE91...The Trump administration signed a Section 123 civilian nuclear cooperation agreement with Saudi Arabia in late July 2026, establishing a framework for U.S. technology transfers and a potential 30-year partnership. However, President Trump subsequently conditioned the deal’s approval on Saudi Arabia normalizing relations with Israel via the Abraham Accords, a step Riyadh has not taken and shows no immediate signs of pursuing amid regional tensions. Under the Atomic Energy Act, the agreement requires submission to Congress for a 90-day review period before it can enter into force, a timeline that already compresses the remainder of 2026. Unresolved details on uranium enrichment, IAEA safeguards, and bipartisan congressional concerns over proliferation risks further complicate prospects. These procedural, diplomatic, and political hurdles underpin trader expectations that the agreement will not take effect this calendar year.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions